vs
IONIS PHARMACEUTICALS INC（IONS）与MACOM Technology Solutions Holdings, Inc.（MTSI）财务数据对比。点击上方公司名可切换其他公司
MACOM Technology Solutions Holdings, Inc.的季度营收约是IONIS PHARMACEUTICALS INC的1.4倍（$289.0M vs $203.3M），MACOM Technology Solutions Holdings, Inc.净利率更高（16.0% vs -112.8%，领先128.9%），MACOM Technology Solutions Holdings, Inc.同比增速更快（22.5% vs -10.3%），过去两年IONIS PHARMACEUTICALS INC的营收复合增速更高（30.4% vs 23.2%）
IONIS制药是1989年成立的生物科技企业，总部位于美国加利福尼亚州卡尔斯巴德，专注于反义疗法、RNA干扰及CRISPR疗法的研发，2015年12月前曾以Isis制药的名称运营。
MACOM是美国知名的射频、微波及毫米波半导体器件与组件研发生产商，总部位于马萨诸塞州洛厄尔，2005年曾是当地规模最大的私营雇主。公司已通过ISO9001国际质量体系认证及ISO14001环境管理体系认证，在北美、欧洲、亚洲及澳大利亚均设有设计中心与销售办事处。
IONS vs MTSI — 直观对比
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $203.3M | $289.0M |
| 净利润 | $-229.4M | $46.3M |
| 毛利率 | 96.1% | 56.9% |
| 营业利润率 | -105.5% | 17.6% |
| 净利率 | -112.8% | 16.0% |
| 营收同比 | -10.3% | 22.5% |
| 净利润同比 | -119.8% | 46.3% |
| 每股收益（稀释后） | $-1.35 | $0.60 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q2 26 | — | $289.0M | ||
| Q1 26 | — | $271.6M | ||
| Q4 25 | $203.3M | $261.2M | ||
| Q3 25 | $156.7M | $252.1M | ||
| Q2 25 | $452.0M | $235.9M | ||
| Q1 25 | $131.6M | $218.1M | ||
| Q4 24 | $226.6M | — | ||
| Q3 24 | $133.8M | $200.7M |
| Q2 26 | — | $46.3M | ||
| Q1 26 | — | $48.8M | ||
| Q4 25 | $-229.4M | $45.1M | ||
| Q3 25 | $-128.6M | $36.5M | ||
| Q2 25 | $123.6M | $31.7M | ||
| Q1 25 | $-146.9M | $-167.5M | ||
| Q4 24 | $-104.3M | — | ||
| Q3 24 | $-140.5M | $29.4M |
| Q2 26 | — | 56.9% | ||
| Q1 26 | — | 55.9% | ||
| Q4 25 | 96.1% | 54.5% | ||
| Q3 25 | 98.5% | 55.3% | ||
| Q2 25 | 99.1% | 55.2% | ||
| Q1 25 | 98.9% | 53.7% | ||
| Q4 24 | 98.3% | — | ||
| Q3 24 | 99.2% | 54.7% |
| Q2 26 | — | 17.6% | ||
| Q1 26 | — | 15.9% | ||
| Q4 25 | -105.5% | 15.2% | ||
| Q3 25 | -102.2% | 14.9% | ||
| Q2 25 | 30.9% | 14.8% | ||
| Q1 25 | -111.6% | 8.0% | ||
| Q4 24 | -48.9% | — | ||
| Q3 24 | -111.1% | 13.7% |
| Q2 26 | — | 16.0% | ||
| Q1 26 | — | 18.0% | ||
| Q4 25 | -112.8% | 17.3% | ||
| Q3 25 | -82.1% | 14.5% | ||
| Q2 25 | 27.3% | 13.4% | ||
| Q1 25 | -111.6% | -76.8% | ||
| Q4 24 | -46.1% | — | ||
| Q3 24 | -105.0% | 14.7% |
| Q2 26 | — | $0.60 | ||
| Q1 26 | — | $0.64 | ||
| Q4 25 | $-1.35 | $0.67 | ||
| Q3 25 | $-0.80 | $0.48 | ||
| Q2 25 | $0.70 | $0.42 | ||
| Q1 25 | $-0.93 | $-2.30 | ||
| Q4 24 | $-0.66 | — | ||
| Q3 24 | $-0.95 | $0.40 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.7B | $664.9M |
| 总债务越低越好 | $1.8B | $0 |
| 股东权益账面价值 | $489.1M | — |
| 总资产 | $3.5B | $2.0B |
| 负债/权益比越低杠杆越低 | 3.71× | — |
8季度趋势，按日历期对齐
| Q2 26 | — | $664.9M | ||
| Q1 26 | — | $768.5M | ||
| Q4 25 | $2.7B | $786.0M | ||
| Q3 25 | $2.2B | $735.2M | ||
| Q2 25 | $2.3B | $681.5M | ||
| Q1 25 | $2.1B | $656.5M | ||
| Q4 24 | $2.3B | — | ||
| Q3 24 | $2.5B | $581.9M |
| Q2 26 | — | $0 | ||
| Q1 26 | — | — | ||
| Q4 25 | $1.8B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | — | — |
| Q2 26 | — | — | ||
| Q1 26 | — | $1.4B | ||
| Q4 25 | $489.1M | $1.3B | ||
| Q3 25 | $618.0M | $1.3B | ||
| Q2 25 | $631.7M | $1.2B | ||
| Q1 25 | $475.7M | $1.2B | ||
| Q4 24 | $588.4M | — | ||
| Q3 24 | $662.5M | $1.1B |
| Q2 26 | — | $2.0B | ||
| Q1 26 | — | $2.1B | ||
| Q4 25 | $3.5B | $2.1B | ||
| Q3 25 | $3.0B | $2.0B | ||
| Q2 25 | $3.0B | $1.9B | ||
| Q1 25 | $2.8B | $1.8B | ||
| Q4 24 | $3.0B | — | ||
| Q3 24 | $3.1B | $1.8B |
| Q2 26 | — | — | ||
| Q1 26 | — | — | ||
| Q4 25 | 3.71× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 2.13× | — | ||
| Q3 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-137.7M | $121.6M |
| 自由现金流经营现金流 - 资本支出 | $-159.0M | — |
| 自由现金流率自由现金流/营收 | -78.2% | — |
| 资本支出强度资本支出/营收 | 10.5% | — |
| 现金转化率经营现金流/净利润 | — | 2.62× |
| 过去12个月自由现金流最近4个季度 | $-320.0M | — |
8季度趋势，按日历期对齐
| Q2 26 | — | $121.6M | ||
| Q1 26 | — | $42.9M | ||
| Q4 25 | $-137.7M | $69.6M | ||
| Q3 25 | $-131.4M | $60.4M | ||
| Q2 25 | $151.3M | $38.7M | ||
| Q1 25 | $-150.8M | $66.7M | ||
| Q4 24 | $-116.1M | — | ||
| Q3 24 | $-115.0M | $62.3M |
| Q2 26 | — | — | ||
| Q1 26 | — | $30.0M | ||
| Q4 25 | $-159.0M | $49.4M | ||
| Q3 25 | $-136.7M | $51.6M | ||
| Q2 25 | $139.0M | $30.5M | ||
| Q1 25 | $-163.4M | $61.3M | ||
| Q4 24 | $-141.6M | — | ||
| Q3 24 | $-124.0M | $57.1M |
| Q2 26 | — | — | ||
| Q1 26 | — | 11.0% | ||
| Q4 25 | -78.2% | 18.9% | ||
| Q3 25 | -87.2% | 20.5% | ||
| Q2 25 | 30.8% | 12.9% | ||
| Q1 25 | -124.1% | 28.1% | ||
| Q4 24 | -62.5% | — | ||
| Q3 24 | -92.7% | 28.5% |
| Q2 26 | — | — | ||
| Q1 26 | — | 4.8% | ||
| Q4 25 | 10.5% | 7.7% | ||
| Q3 25 | 3.4% | 3.5% | ||
| Q2 25 | 2.7% | 3.5% | ||
| Q1 25 | 9.6% | 2.4% | ||
| Q4 24 | 11.3% | — | ||
| Q3 24 | 6.8% | 2.6% |
| Q2 26 | — | 2.62× | ||
| Q1 26 | — | 0.88× | ||
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | 1.65× | ||
| Q2 25 | 1.22× | 1.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.12× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IONS
| Products | $58.0M | 29% |
| Spinraza Royalties | $54.0M | 27% |
| Collaborative Agreement Revenue | $52.4M | 26% |
| Wainus Royalties | $16.0M | 8% |
| Wainua Joint Development Revenue | $9.6M | 5% |
| Other Commercial | $7.6M | 4% |
| Other Royalties | $5.7M | 3% |
MTSI
暂无分部数据
